Removing water from the crystal lattice yields stable Form B, resolving hydrate unpredictability and improving solubility control.
Multi-component herbal formulation suppresses pro-inflammatory cytokines and restores colonic architecture to address adverse effects of Western therapies.
A phospholipid vesicle tissue marker combines near-infrared dyes with X-ray contrast media to enable precise external organ identification.
Microparticulate formulations use pH-dependent release polymers to protect cannabinoids from stomach acid and enable targeted intestinal delivery.
Heating element converts heavy metal salt solution into inhalable aerosol, bypassing systemic circulation to reduce medication concentration and lag time.
Plant-mediated synthesis eliminates toxic chemical reagents while generating antifungal nanoparticles effective against drug-resistant Aspergillus fumigatus.
Composite oral formulation pairs Bifidobacterium breve MCC1274 with cruciferous vegetables to inhibit body weight gain without increasing bacterial complexity.
Single-use sterile tiotropium units eliminate preservative-induced bronchoconstriction while ensuring accurate dosing via pre-measured containers.
Denatured plant protein encapsulates probiotic bacteria in a neutral pH matrix, avoiding acidic conditions that reduce cell counts.
Microwave heating of perrhenic acid yields rhenium sulfide particles with defined size, avoiding alkali impurities for radioisotope therapy.
Liposomal carriers enhance mucus penetration and sustain drug concentration, reducing bacterial density in cystic fibrosis lungs.
Chlorine dioxide oxidizes viral spike proteins to inactivate SARS-CoV-2, bypassing mutation-induced vaccine resistance.
Sugar coated API granules reduce vacuum pressure requirements and prevent straw clogging during oral administration.
Liquid pharmaceutical composition with reduced preservatives maintains microbial stability through active substance intrinsic activity.
Solidago extract composition treats diabetic periodontitis without acute toxic effects.
A solid beverage formulation combines smoked plum, perilla, and lilium brownii with dextrin carriers to deliver therapeutic compounds in a palatable granule.
Self-emulsifying oil-in-water emulsions form upon saliva contact to enable rapid transmucosal absorption of biologically active peptides.
Hordeum vulgare extract promotes longitudinal bone growth, avoiding side effects of costly growth hormone therapy.
Vibrating mesh nebulizers deliver low molecular weight heparin as an aerosol cloud directly to the lungs.
Lactobacillus plantarum TCI507 modulates SCARB1, APOA1, and LDLR gene expression to reduce total cholesterol without synthetic drug side effects.
Edible melanin supplements shield subjects from ionizing radiation through direct free radical scavenging and energy dissipation mechanisms.
Dry polyethylene glycol composition reduces administered volume from four liters to two liters while minimizing fluid absorption and electrolyte imbalance.
Sequestered calcium beta-hydroxy-beta-methylbutyrate stabilizes protein formulations, enabling safe muscle building for diabetic and kidney patients.
Heating a mixture of topiramate, PEG 400, and glycerol achieves a clear solution phase that maintains high drug concentrations without precipitation.
Surface-bound PPACK nanoparticles delay thrombus formation while maintaining normal systemic plasma clotting times.
Modified apolipoproteins bind scavenger receptors on macrophages, concentrating gadolinium contrast agents at target sites while reducing systemic toxicity.
Adrenocorticotropic hormone peptides modulate inflammation and steroidogenesis to alleviate lung damage in acute respiratory distress syndrome.
Topiramate oral liquid suspension resolves adverse reaction and stability trade-offs through pH adjustment and taste-masking agents.
Amino acid nitrate salts improve water solubility to overcome low bioavailability and reduce nitrate tolerance in conventional supplements.
Synergistic herbal extracts inhibit phosphodiesterase 5 enzyme activity to increase cyclic GMP levels in male subjects.
Piper longum L. extract targets M3 and beta3 receptors to inhibit detrusor contraction, resolving adverse effects from broad anticholinergic treatments.
A breath-actuated inhaler triggers tiotropium release via pneumatic resistance to prevent accidental valve activation.
Mucosal cytokine administration induces specific aversions to addictive substances, reducing reliance on willpower and minimizing systemic side effects.
Selective alpha-amino ester compounds target the FP receptor to delay preterm labor while minimizing systemic side effects on mother and fetus.
Stepwise heated egg white protein introduction reduces infant allergy incidence by managing eczema and minimizing allergic reaction risks.
Combining Opuntia ficus indica with Bergamot extract reduces lipid and glucose levels without pharmaceutical side effects.
Dissolving cannabidiol in ethanol prevents precipitation while mitigating alcohol-induced neurodegeneration.
NHS-ADIBO surface treatment enables stable radioactive labeling, avoiding background fluorescence interference in vivo.
Non-volatile excipients maintain particle size above 0.5 μm during inhalation, preventing evaporation-induced shrinkage and ensuring optimal lung deposition.
Maltitol and alcoholate mask arginine salt bitterness, enabling direct oral administration of high doses without water.
Nanoparticles concentrate pitavastatin at lung lesions, avoiding high systemic doses that cause rhabdomyolysis.
Polyhydric alcohol solvents mask methisoprinol bitterness, enabling stress-free oral dosing and prolonged antiviral activity.
PEG 400 and glycerol prevent hydrolytic degradation of topiramate, maintaining stability during storage.
Direct-fed Bacillus strains alter gut parameters to reduce death loss and enhance milk production volume.
Replacing water with organic solvents prevents precipitation, enabling stable high-concentration cannabinoid formulations.
Aprotinin aerosol formulation maintains stability in gas-tight containers to treat respiratory viral infections.
Crystal form A amidine derivative oral formulation overcomes solubility and permeability barriers to enable effective hereditary angioedema treatment.
Peptide amphiphile compositions maintain structural integrity during nebulization to deliver sustained drug release while resisting mechanical disruption.
Eriodictyol mediates between guaifenesin and bitter taste receptors, reducing unpleasant flavor perception by 35-40% without adding sweeteners.
A pharmaceutical composition combining polyols with dietary fiber to soften stool through intestinal water absorption.